Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPFF versus calcium dobesilate for pelvic congestion syndrome symptoms in adult women
IRCT20250604066065N1Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pelvic varices (PCS) comparing MPFF with Calcium dobesilate (2 arms). Primary endpoints: Improvement in pelvic congestion syndrome symptoms, Pelvic pain reduction and 6 more. Started Sep 2025; status: completed.
02
Drugs
diosmincalcium dobesilate
03
Conditions
pelvic varices (PCS)
Beyond the preview
Go deeper on IRCT20250604066065N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250604066065N1.